|
|
||||||||
The Journal of Immunology, Vol 147, Issue 10 3331-3335, Copyright © 1991 by American Association of Immunologists
ARTICLES |
T Berney, T Shibata and S Izui
Department of Pathology, University of Geneva, Switzerland.
A murine IgG3 mAb, 6-19, derived from autoimmune MRL-lpr/lpr mice, is a rheumatoid factor (RF) specific for IgG2a and is able to generate cryoglobulins via nonspecific IgG3 Fc-Fc interaction. Intra-peritoneal passive transfer of ascites containing the 6-19 mAb into BALB/c mice induces skin leukocytoclastic vasculitis and acute glomerulonephritis associated with cryoglobulinemia. Because IgG3 interact with each other, we have determined whether noncryoprecipitating IgG3 mAb were able to inhibit the cryoprecipitation of 6-19 mAb and the development of related tissue lesions. In vitro, the cryoprecipitation of 6-19 mAb was almost completely inhibited by a fourfold excess of a noncryoprecipitating non-RF IgG3 (9-106) mAb derived from MRL-lpr/lpr mice. Cryoprecipitation of five other IgG3 mAb was similarly inhibited by the 9-106 mAb, and two other noncryoprecipitating IgG3 mAb, including the 2-6D antinuclear autoantibody, inhibited the cryoprecipitation of 6-19 mAb. In vivo, pretreatment of BALB/c mice with 9-106 or 2-6D mAb prevented the development of skin vasculitis and glomerulonephritis induced by the 6-19 mAb. The cryoglobulin formation was greatly diminished in 9-106 or 2-6D mAb-treated mice, although their serum levels of 6-19 mAb and RF activity were comparable to those of control mice. This indicated that pretreatment with non-cryoglobulin IgG3 inhibited the cryoglobulin generation and cryoglobulin-associated tissue lesions induced by an IgG3 RF cryoglobulin-generating mAb. These results suggest that the balance of formation of IgG3 autoantibodies with or without the cryoglobulin activity may be critical for the development of IgG3 cryoglobulin-mediated tissue lesions in murine lupus, particularly in MRL-lpr/lpr mice.
This article has been cited by other articles:
![]() |
Y. Kuroda, A. Kuroki, S. Kikuchi, T. Funase, M. Nakata, and S. Izui A Critical Role for Sialylation in Cryoglobulin Activity of Murine IgG3 Monoclonal Antibodies J. Immunol., July 15, 2005; 175(2): 1056 - 1061. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kuroki, Y. Kuroda, S. Kikuchi, F. Lajaunias, T. Fulpius, Y. Pastore, L. Fossati-Jimack, L. Reininger, T. Toda, M. Nakata, et al. Level of galactosylation determines cryoglobulin activity of murine IgG3 monoclonal rheumatoid factor Blood, April 15, 2002; 99(8): 2922 - 2928. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Feeney, B. R. Lawson, D. H. Kono, and A. N. Theofilopoulos Terminal Deoxynucleotidyl Transferase Deficiency Decreases Autoimmune Disease in MRL-Faslpr Mice J. Immunol., September 15, 2001; 167(6): 3486 - 3493. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-U. Rengers, G. Touchard, C. Decourt, S. Deret, H. Michel, and M. Cogne Heavy and light chain primary structures control IgG3 nephritogenicity in an experimental model for cryocrystalglobulinemia Blood, June 1, 2000; 95(11): 3467 - 3472. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Wang and M. J. Shlomchik Maternal Ig Mediates Neonatal Tolerance in Rheumatoid Factor Transgenic Mice but Tolerance Breaks Down in Adult Mice J. Immunol., March 1, 1998; 160(5): 2263 - 2271. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Chan and M. J. Shlomchik A New Role for B Cells in Systemic Autoimmunity: B Cells Promote Spontaneous T Cell Activation in MRL-lpr/lpr Mice J. Immunol., January 1, 1998; 160(1): 51 - 59. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |